
Indoco Remedies Limited has informed the Exchange regarding a press release dated September 14, 2020, titled "Indoco receives USFDA approval for Apixaban Tablets".
Filed with NSE ·

Indoco Remedies Limited has informed the Exchange regarding a press release dated September 14, 2020, titled "Indoco receives USFDA approval for Apixaban Tablets".
6ix hasn’t read this filing yet.
Indoco Remedies Limited on 6ix
Follow Indoco Remedies into a list and get an email when it puts out news.
Follow Indoco Remedies